United Therapeutics CorporationUTHRNASDAQ
LOADING
|||
Net Income Scaling
Trending higher, above historical average, modest growth trend.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$1.20B
↑ 94% above average
Average (9y)
$616.57M
Historical baseline
Range
High:$1.20B
Low:$-104.50M
CAGR
+7.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $1.20B | +21.4% |
| 2023 | $984.80M | +35.4% |
| 2022 | $727.30M | +52.9% |
| 2021 | $475.80M | -7.6% |
| 2020 | $514.80M | +592.6% |
| 2019 | $-104.50M | -117.7% |
| 2018 | $589.20M | +41.0% |
| 2017 | $417.90M | -41.4% |
| 2016 | $713.70M | +9.5% |
| 2015 | $651.64M | - |